Xencor (XNCR) Cash from Investing Activities (2013 - 2026)

Xencor's (XNCR) quarterly Cash from Investing Activities came in at $26.7 million in Q1 2026, up 95.18% year-on-year from $13.7 million in Q1 2025, and down 62.52% on a QoQ basis from $71.2 million in Q4 2025.

Xencor (XNCR) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Cash from Investing Activities data on file, last reported at $26.7 million in Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 95.18% year-over-year to $26.7 million in Q1 2026; TTM through Mar 2026 was $153.0 million, a 676.86% increase from a year earlier, with the FY2025 full-year figure at $140.0 million, up 1878.26% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at $26.7 million, down from $71.2 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for XNCR reached as high as $71.2 million in Q4 2025 and fell as low as -$203.1 million in Q4 2023.
  • Historically, Cash from Investing Activities has averaged -$4.2 million across 5 years, with a median of $24.5 million in 2022.
  • Across the five-year window, Cash from Investing Activities plunged 927.48% in 2023 and surged 4798.65% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at $24.5 million in 2022, then plunged by 927.48% to -$203.1 million in 2023, then jumped by 128.18% to $57.3 million in 2024, then climbed by 24.32% to $71.2 million in 2025, then plunged by 62.52% to $26.7 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were $26.7 million in Q1 2026, $71.2 million in Q4 2025, and $14.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Xencor 1.49 Bn 1.11 Bn - 26.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 26.68 Mn
Mar 31, 2026 26.68 Mn
Dec 31, 2025 71.17 Mn
Dec 31, 2025 71.17 Mn
Sep 30, 2025 14.67 Mn
Sep 30, 2025 14.67 Mn
Jun 30, 2025 40.48 Mn
Jun 30, 2025 40.48 Mn
Mar 31, 2025 13.67 Mn
Mar 31, 2025 13.67 Mn
Dec 31, 2024 57.25 Mn
Dec 31, 2024 57.25 Mn
Sep 30, 2024 -163.46 Mn
Sep 30, 2024 -163.46 Mn
Jun 30, 2024 66.02 Mn
Jun 30, 2024 66.02 Mn
Mar 31, 2024 32.32 Mn
Mar 31, 2024 32.32 Mn
Dec 31, 2023 -203.13 Mn
Dec 31, 2023 -203.13 Mn